scholarly journals Effect of the combination of Leptadenia hastata (pers) decne and Momordica balsamina linn leaf extracts on lipid profile of streptozotocin-induced diabetic rats

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Nafisatu Kabir ◽  
Umar Ismail Alhaji ◽  
Dorcas Bolanle James ◽  
Hajia Mairo Inuwa ◽  
Muhammad Kano Atiku

Abstract Background Changes in blood lipid level (dyslipidemia) play a central role in the onset and pathogenesis of macrovascular complications of diabetes mellitus. Traditional herbal healers commonly use anti-diabetic polyherbal formulations to provide a multi-therapeutic approach for the treatment of diabetes mellitus and its associated complications. The effect of the aqueous leaf extracts of Leptadenia hastata (pers) Decne, Momordica balsamina Linn and their combination on lipid profile of streptozotocin (STZ)-induced diabetic rats was therefore evaluated in the present study. Results We evaluated the serum lipid profile and blood glucose level of STZ-induced diabetic rats (60 mg/kg body weight) treated with the aqueous leaf extracts of L. hastata (400 mg/kg) and M. balsamina (200 mg/kg) alone and in combination (400 + 200 mg/kg) after a period of 4 weeks. A significantly decreased (p < 0.05) level of total cholesterol (TC), triglyceride (TG), very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) cholesterol levels and increased (p < 0.05) level of high-density lipoprotein (HDL) cholesterol was observed in all the treated groups when compared to the untreated diabetic rats. Furthermore, the combination treatment was potentially a more effective blood lipid-lowering (p < 0.05) agent when compared to the single treatments. Conclusion Results from this study demonstrated the blood lipid-lowering potential of the aqueous leaf extracts of L. hastata, M. balsamina, and their combination. However, the polyherbal combination could be more potent in controlling diabetes mellitus, associated dyslipidemia, and its complications.

2021 ◽  
Vol 11 (3) ◽  
pp. 066-071
Author(s):  
Babafemi Tosin Ogunbiyi ◽  
Gogonte Hezekiah Amah ◽  
Laide Omoyiola Olajide ◽  
Olubunmi Esther Ogunbiyi ◽  
Oluwafunmilola Christiana Adetunji ◽  
...  

Diabetes mellitus is a complex multifarious metabolic disorder characterized by chronic hyperglycemia that requires non-stop treatment with multiple factors that will reduce the risk of long-term complications and drug side effects. Streptozotocin is well known for its selective pancreatic islet β-cell cytotoxicity used to induce diabetes mellitus in animals. It also interferes with cellular metabolic oxidative mechanisms. Phytomedicine has been in existence since the primitive age and has proven to be effective in treating this condition. This study was aimed at evaluating the effect of Gangaria de flush (Gdf) herbal mixture on lipid profile in streptozotocin (STZ) (60mg/kg) induced diabetic rat. The diabetic rats were treated with Gangaria de flush (0.3ml/kg body weight) and Glibenclamide (5mg/kg body weight) for 7days. The effects of both Gangaria de flush herbal mixture and glibenclamide were analyzed. Gangaria de flush showed a reduction in the lipid profile with a significant percentage reduction of 45.9% for the total cholesterol, 65.7% for the total triglyceride, 63.5% for the low-density lipoprotein, 65.8% for the very low-density lipoprotein as against the negative control and a 7.6% significant increase in the high density lipoprotein. Gangaria de flush showed a significant (p<0.05) positive effect on the lipid profile. Hence, it can be suggested that Gangaria de flush herbal mixture has a significant effect in maintaining the lipid level.


Author(s):  
Bhagwan Das ◽  
Durgesh Kumar ◽  
Munish Kumar

Background: Diabetes mellitus refers to a group of common metabolic disorders that share the phenotype of hyperglycemia. Type 2 Diabetes Mellitus (DM) is a heterogeneous group of disorders characterized by variable degree of insulin resistance, impaired insulin secretion, and increased glucose production.Methods: To study of pattern of lipid profile in type 2 diabetes mellitus, 100 cases of type 2 Diabetes Mellitus attending the tertiary care centre were selected. The result was compared with 25 healthy, non-obese, non- diabetic and non-hypertensive subjects.Results: Triglyceride (TG) and very low-density lipoprotein (VLDL) were significantly higher whereas high density lipoprotein (HDL) levels lower in diabetics than healthy controls. Total cholesterol (TC) and low-density lipoprotein (LDL) were other fractions which were slightly above optimal levels in diabetics.Conclusions: From our study, it was concluded that diabetes mellitus has a real impact on lipid metabolism.


2019 ◽  
pp. 40-52
Author(s):  
Maksim Maksimov ◽  
Anastasia Shikaleva ◽  
Aleksandra Kuchaeva

Representatives of different groups of lipid-lowering drugs may have some differences in the nature and severity of the effect on the blood lipid spectrum. A new class of drugs, PCSK9 inhibitors, whose activity is associated with a protein involved in the control of low density lipoprotein receptors, has recently appeared. In clinical practice, this group is represented by monoclonal antibody preparations evolocumab and alirocumab. PCSK9 inhibitors are promising drugs for use in combination lipid-lowering therapy, which so far, given the results of clinical studies, can be recommended in the third place after statins and ezetimibe. In clinical studies, it was shown that alirocoumab and evolocumab alone or in combination with statins and/or other lipid-lowering drugs significantly reduce cholesterol levels in low density lipoproteins – by an average of 60%, depending on the dose.


2017 ◽  
Vol 21 (2) ◽  
pp. 112-116
Author(s):  
Sandip S Sendhav ◽  
Amit Kakaiya ◽  
Bijoya Chatterjee

ABSTRACT Aims and objectives Diabetes is a common endocrinal disorder. Abnormal lipid and magnesium levels are observed in diabetes in many studies. The current study was done with an aim to find the relationship between lipid with magnesium and diabetes mellitus in Gujarati population. Materials and methods The cross-sectional study included 60 diabetics and 50 healthy subjects. Each subject was interviewed, examined, and investigated for serum lipid profile and magnesium. A 12-hour overnight fasting was recommended. The statistical analysis of data obtained was done by Student's t-test and calculation of Pearson correlation coefficient. Result Routine biochemical investigations showed a significant rise (p < 0.01) of fasting plasma glucose, triglycerides (TGs), total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), and very low-density lipoprotein-cholesterol (VLDL-C) in diabetics, in comparison with controls (p < 0.01). Among diabetics, males have significantly higher (p < 0.01) TC, TG, and LDL-C while significantly lower high-density lipoprotein-cholesterol (HDL-C). Significant inverse correlation of magnesium with TC (r = −0.18), TGs (r = −0.14), LDL-C (r = −0.27), fasting blood sugar (FBS; r = −0.12) and direct correlation with HDL-C (r = 026) were observed in cases. Conclusion The major highlights of the current study are lower magnesium levels in cases compared with controls. In the current study, serum magnesium level has been found to be inversely related to cholesterol, TG, and LDL-C levels, while it is directly associated with HDL-C level. Hence, it could play a role in controlling the risk of coronary artery disease (CAD)-associated morbidities in future. How to cite this article Sendhav SS, Kakaiya A, Chatterjee B. Evaluation of Serum Magnesium Level along with Lipid Profile in a Gujarati Population diagnosed with Diabetes Mellitus. Indian J Med Biochem 2017;21(2):112-116.


2020 ◽  
Vol 7 (5) ◽  
pp. 1038
Author(s):  
Kanwalpreet Kaur ◽  
Karuna Thapar ◽  
Preeti Malhotra

Background: To compare the cord blood lipid profile of 100 newborn babies born to hypertensive (Group A) and normotensive mothers (Group B).Methods: Total 100 newborns were taken, 50 born to hypertensive mothers and 50 to normotensive mothers. 5ml umbilical venous blood was collected, after clamping the cord, from placental side of the cord and sent to laboratory for centrifugation. Serum was analysed for lipid profile by spectrophotometry by siemens dimensional Rxl- Total Cholesterol, Triglycerides, High density lipoprotein and Low density lipoprotein and Very low density lipoprotein. Comparison of the cord blood lipid levels in both the groups was done.Results: Cord blood lipid profile was deranged in newborns of hypertensive mothers with Cord TC, TG and LDL being statistically significantly higher than the mean reference value and 95th centile. Cord blood of term newborns of hypertensive mothers had Cord TC TG and LDL being statistically higher whereas only Cord TC being statistically higher in preterm neonates of hypertensive mothers.Conclusions: Cord blood lipid levels were significantly deranged in newborns of hypertensive mothers. This helps us in providing the target population at risk and cord blood lipid profile of newborn serving as an indirect guide for lifestyle modifications and helping in early intervention and prevention of future coronary heart disease.


2013 ◽  
Vol 20 (03) ◽  
pp. 360-364
Author(s):  
MUHAMMAD TANVEER ALAM ◽  
HARILAL KHIEMANI ◽  
AMIR SHAHZAD MALIK ◽  
Muhammad Aurengzeb ◽  
Mukhtiar Pathan ◽  
...  

Objective: The objective of this study is to determine the pattern dyslipidimia in patients of Type 2 diabetes mellitus. StudyDesign: Cross-sectional study. Place and Duration: This study was carried out in General Medicine department of Peoples MedicalUniversity & Hospital Nawabshah and Civil Hospital Karachi, from June 2011 to July 2012. Methodology: This study consisted of seventypatients. Detailed history was taken from all the patients with special regard to increased thirst and frequent urination, increased hunger,weight loss, fatigue, blurred vision, slow-healing sores or frequent infections and an areas of darkened skin. Inclusion criteria were that allpatients after counseling for study and taking written consent were included in this study >35 years of age with either sex admitted ingeneral medicine ward through outpatient department and diagnosed as case of DM type 2 on the basis of history , clinical examinationand investigations. Exclusion criteria included patients on dialysis, patients on lipid lowering agents, patients with acute complication ofdiabetes mellitus such as diabetic keto-acidosis, patients suffering from hypothyroidism, nephritic syndrome, type 1 DM and HTN, lacticacidosisand hypoglycemia. Results were prepared with the help of tables and graphs. Data was analyzed through SPSS software.Results: Out of 70 patients included in this study 46 were men (65.8%) and 24 patients were female (34.2%); with male to female ratio of1.9:1. There was wide variation of age ranging from a minimum of 35 year to 75 year. The mean age was 48.65+7.8 years. Mean totalserum cholesterol was 196.04 ± 44.02mg/dl, mean serum triglycerides was 193.04 ± 108.64 mg/dl , mean high density lipoprotein29.28 ± 8.48mg/dl, mean low density lipoprotein 125.24 ± 39.68mg/dl and mean very low density lipoprotein was 31.28 ± 8.48 mg/dl.Total cholesterol was abnormal (>200mg/dl) in 56(80%) patients out of 70[ 21(87.5%) were females and 35 (76.1%) were males],Triglycerides was abnormal (>150mg/dl) in 62(88.5%) patients [ 22 (91.66 %) were females and 40 (86.95%) were males], high densitylipoprotein was abnormal (< 35 mg/dl) in 51(72.8%) patients[ 18(75%) were females and 33(71.73%) were males], LDL was abnormal(>130 mg/dl) in 40(57.1%) patients [ 17 (70.83%) were females and 23(50%) were males] and VLDL was abnormal (> 30 mg/dl) in47(67.14%) patients [19(79.16%) were females and 28(60.86%) were males]. Conclusions: We conclude that dyslipidemia is commonamong type 2 diabetic patients. Males are more prone to suffer from this complication. Patterns of dyslipidemia found more commonlywere decreased HDL levels, increased LDL and Triglycerides levels. There is a need for early detection and treatment of this problem toprevent type 2 diabetic complications .


Open Medicine ◽  
2021 ◽  
Vol 17 (1) ◽  
pp. 70-86
Author(s):  
Fatemeh Alsadat Rahnemaei ◽  
Reza Pakzad ◽  
Azam Amirian ◽  
Iraj Pakzad ◽  
Fatemeh Abdi

Abstract Gestational diabetes mellitus (GDM) can have adverse effects on pregnancy. GDM is associated with changes in the lipid profile of pregnant women. Finding out the early ways to diagnose GDM can prevent the adverse outcomes. This meta-analysis study aimed to determine the effect of GDM on lipid profile. PubMed, ProQuest, Web of Science, Scopus, Science Direct, Google Scholar, and ClinicalTrial were systematically searched for published articles relating to GDM until 2021 according to PRISMA guidelines. Newcastle Ottawa scale was used to assess the quality of the studies. Thirty-three studies with a sample size of 23,792 met the criteria for entering the meta-analysis. Pooled standardized mean difference (SMD) for total cholesterol (TC) and triglyceride (TG) was 0.23 mg/dL (95% CI: 0.11–0.34) and 1.14 mg/dL (95% CI: 0.91–1.38), respectively. The mean of TC and TG in people with GDM was higher than that in normal pregnant women. A similar pattern was observed for the very low-density lipoprotein (VLDL) and TG/high-density lipoprotein (HDL) ratio, with pooled SMD of 0.99 mg (95% CI: 0.71–1.27) and 0.65 mg (95% CI: 0.36–0.94), respectively. Pooled SMD for HDL was −0.35 mg/dL (95% CI: −0.54 to −0.16), women with GDM had a mean HDL lower than normal pregnant women. Although pooled SMD was higher for low-density lipoprotein (LDL) in the GDM group, this difference was not significant (0.14 [95% CI: −0.04 to 0.32]). Of all the lipid profiles, the largest difference between the GDM and control groups was observed in TG (SMD: 1.14). Elevated serum TG had the strongest effect on GDM. Higher levels of TC, LDL, VLDL, and TG/HDL ratio, and lower level of HDL were exhibited in GDM group. So, these markers can be considered as a reliable marker in the diagnosis of GDM.


2017 ◽  
Vol 6 (1) ◽  
pp. 119-125
Author(s):  
Charlie Slowey

Abstract Context: There are numerous studies on the effects of smoking and antiretroviral use separately on a HIV patient’s blood lipid profile, however there has never been a study conducted that measures the intensity of cigarette use combined with antiretroviral therapy on a patient’s blood lipid profile. Aims: To assess the effects of the intensity of cigarette usage and antiretroviral therapy on a patient’s blood lipid profile. Setting and Design: This cross-sectional study was carried out in a regional HIV clinic in Cork University Hospital between June 2016 and August 2016. Methods: 40 patients were interviewed in order to gather cigarette usage data and patient files were reviewed in order to gather blood lipid profile results and antiretroviral therapy data. Results: There was no statistically significant difference (P>0.05) in the means of cholesterol (4.99 vs 5.47), high-density lipoprotein (1.22 vs 1.07), low-density lipoprotein (3.13 vs 3.03), nor triglycerides (1.54 vs 2.45) in smokers versus non-smokers. Low-density lipoprotein in mild and moderate smokers was increased compared to non-smokers. Conclusions: These results show that smoking combined with nucleoside reverse transcriptase inhibitor use has no significant change in blood lipid measurements when compared to controls.


Sign in / Sign up

Export Citation Format

Share Document